R Squared Ltd Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)
R Squared Ltd purchased a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, according to its ...
CRBP stock touches 52-week low at $9.26 amid market challenges
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, trading at $9.26, as investors respond to a series of market headwinds. According to InvestingPro data, the stock's ...
Hosted on MSN22h
AdAlta boosts leadership in Q2 FY25 to support growth strategy
FY25 saw AdAlta focus on increasing its corporate muscle, with two new board members and additional advisors engaged. ...
PipelineReview.com16h
Bayer files for approval of finerenone in heart failure in the EU
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...